Zobrazeno 1 - 10
of 32
pro vyhledávání: '"H R, Scholte"'
Autor:
H. R. Scholte, Roselie Jongbloed, J.P.M. Geraedts, J. B. C. de Klerk, H. J. M. Smeets, J.G. Nijland, I.F.M. de Coo, L.J.A.M. Jacobs, Frits A. Wijburg
Publikováno v:
Journal of Inherited Metabolic Disease, 27, 47-55. Springer Netherlands
Journal of inherited metabolic disease, 27(1), 47-55. Springer Netherlands
Journal of inherited metabolic disease, 27(1), 47-55. Springer Netherlands
Pearson syndrome is an often fatal multisystem disease associated with mitochondrial DNA rearrangements. Here we report a patient with a novel mtDNA deletion of 3.4 kb ranging from nucleotides 6097 to 9541 in combination with deletion dimers. The mut
Autor:
H. J. Breuking, M. H. M. Verduin, T. Wensing, R. van den Hoven, A. E. F. H. Meijer, H. R. Scholte, J. D. Ross
Publikováno v:
Equine Veterinary Journal. 23:142-144
Publikováno v:
Molecular and cellular biochemistry. 174(1-2)
We modified the isolation procedure of muscle and heart mitochondria. In human muscle, this resulted in a 3.4 fold higher yield of better coupled mitochondria in half the isolation time. In a preparation from rat muscle we studied factors that affect
Effect of lamivudine on morphology and function of mitochondria in patients with chronic hepatitis B
Autor:
Pieter E. Zondervan, L. H. P. M. Rademakers, J. van den Berg, P. Honkoop, H. R. Scholte, R.A. de Man, Solko W. Schalm
Publikováno v:
Hepatology (Baltimore, Md.). 26(1)
Nucleoside analogues can induce mitochondrial dysfunction leading to severe clinical syndromes. Lamivudine, a new nucleoside analogue, is an active inhibitor of hepatitis B viral replication without apparent clinical toxicity. To assess subclinical m
Publikováno v:
European Heart Journal, 84-90. Oxford University Press
ISSUE=18;STARTPAGE=84;ENDPAGE=90;ISSN=0195-668X;TITLE=European Heart Journal
ISSUE=18;STARTPAGE=84;ENDPAGE=90;ISSN=0195-668X;TITLE=European Heart Journal
In animal studies, prolonged periods of ischaemia decrease the cardiac carnitine content. However, whether in humans the heart loses carnitine during short-term ischaemia, and whether this is related to ischaemia-induced cardiac dysfunction, is as ye
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35dacb6393f3de894fe3c01e52ded4b9
https://pure.eur.nl/en/publications/da237c53-0ef6-4cb0-8a2a-4eacb5158d67
https://pure.eur.nl/en/publications/da237c53-0ef6-4cb0-8a2a-4eacb5158d67
Publikováno v:
Contributions to nephrology. 98
Publikováno v:
Tijdschrift voor kindergeneeskunde. 58(5)
When patients suffer from hepato-encephalopathy, (cardio)myopathy, dystrophy, hypoglycaemia, some metabolic diseases and several other disease states, carnitine deficiency should be considered. In this article a survey is given of the pathophysiology
Autor:
H R, Scholte, R, Rodrigues Pereira, P C, de Jonge, I E, Luyt-Houwen, M, Hedwig, M, Verduin, J D, Ross
Publikováno v:
Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie. 28(5)
Carnitine deficiency can be defined as a decrease of intracellular carnitine, leading to an accumulation of acyl-CoA esters and an inhibition of acyl-transport via the mitochondrial inner membrane. This may cause disease by the following processes. A